Science Market Update

Colorado Researchers Make Breakthrough on Type I Diabetes

Posted by Cat Girton on Wed, Apr 13, 2016

Diabetes encompasses a group of metabolic disorders that result in chronically elevated blood sugar levels. If untreated, these diseases can result in serious complications such as ketoacidosis, heart disease, kidney failure, and stroke. The most common type of diabetes is type II diabetes, which accounts for 90-95% of cases (a recent Philadelphia study helped us gain further insight into why type II diabetes occurs). The incidence of type I diabetes is much lower, accounting for just 5-10% of cases. However, while type II diabetes can resolve on its own with changes in diet and exercise habits, type I is considered incurable. Now, a new study from the University of Colorado, Anschutz Medical Campus has identified a new class of antigens that may be a factor in the development of the disease.

Read More

Tags: Diabetes, University of Colorado Anschutz Medical Campus, autoimmune disease, insulin resistance, lab supplies, Research, Type 1 Diabetes, life science tradeshows, T Cells

Rockefeller Researchers Make Advances with HIV Vaccine

Posted by Robert Larkin on Tue, Jul 07, 2015

In collaboration with researchers at The Scripps Research Institute, Weill Cornell Medical College, and other institutions, scientists at Rockefeller University are working to harness the natural potential of the human immune system to develop a series of sequential vaccinations against the HIV virus. 

Read More

Tags: Rockefeller University, Bioresearch, HIV, Bioscience, infectious diseases, New York, 2015, disease research, RockU, BioResearch Product Faire Event, NY, NIH, Northeast Region, AIDS vaccine research, life science tradeshows

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!